“At the same time, VC combined with TMZ decreased the expression level of p-ERK1/2-related protein in BMG-1 and SHG44 cells, and increased the apoptosis rate (P<0.05).”
“Conclusion: VC combined with temozolomide can enhance the toxicity of glioma cells.”